B-type natriuretic peptide (BNP) and fibroblast growth factor 23 (FGF23) were previously identified from an initial pool of 92 biomarkers to be strongly associated with prevalent AF in a cohort of consecutive patients presenting to hospital [6]. The gene discussed is NPPB; the disease is atrial fibrillation.